Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
  • Press shift tab to select search category
    Loading...
  •  United States
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
    • Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Science
      < Back
    • Science
    • Areas of Focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patients
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Untitled
  3. Financial Calendar events

H1 2022 results

Post navigation

Previous
Next

H1 2022 results

H1 2022 results

- 28 July 2022 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook
  • Share on Email

Related Events

06 June 2023

Dividend payment date
26 October 2023

YTD 2023 Sales
02 June 2023

Ex-dividend date
31 May 2023

Annual shareholders meeting
27 July 2023

H1 2023 results
09 February 2023

FY 2022 results
27 April 2023

Q1 2023 sales
24 May 2022

Annual Shareholders’ Meeting
31 May 2022

Ex-dividend date
02 June 2022

Dividend payment date

IPN price

€167.50

 €2.40 (1.45%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2026

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue